Franchise opportunities compared

    Discovery Map International vs Galt Pharmaceuticals

    Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.

    Initial investment · Item 7

    Discovery Map International

    $29,250

    2026 FDD · Item 7 · PDF p. 13

    Galt Pharmaceuticals

    $122,350 – $348,700

    2026 FDD · Item 7 · PDF p. 21

    Initial franchise fee · Item 5

    Discovery Map International

    $25,000

    2026 FDD · Item 5 · PDF p. 10

    Galt Pharmaceuticals

    $100,000

    2026 FDD · Item 5 · PDF p. 13

    Royalty · Item 6

    Discovery Map International

    10% print; 25% website ads

    2026 FDD · Item 6 · PDF p. 10

    Galt Pharmaceuticals

    Not available

    Before you compare

    • Both sets of figures come from 2026 FDDs.
    • Item 19 figures cover the location groups each FDD names (Discovery Map International: 3, Galt Pharmaceuticals: 4). Different groups are not directly comparable.

    Financial commitment

    Estimated initial investment (Item 7)

    Discovery Map International

    $29,250
    Total estimated initial investment low/
    2026 FDD · Item 7 · PDF p. 13

    Galt Pharmaceuticals

    $122,350 – $348,700
    Total initial investment: $122,350 to $348,700
    2026 FDD · Item 7 · PDF p. 21
    Standard initial franchise fee (Item 5)

    Discovery Map International

    $25,000
    2026 FDD · Item 5 · PDF p. 10

    Galt Pharmaceuticals

    $100,000
    The FDD also lists a past-fiscal-year initial franchise fee range of $125,000 to $300,000.
    2026 FDD · Item 5 · PDF p. 13
    Royalty (Item 6)

    Discovery Map International

    10% print; 25% website ads
    Royalty on website ads
    2026 FDD · Item 6 · PDF p. 10

    Galt Pharmaceuticals

    Not available
    No reviewed royalty record
    Brand / advertising fund (Item 6)

    Discovery Map International

    10%
    Royalty on printed advertising — 10%
    2026 FDD · Item 6 · PDF p. 10

    Galt Pharmaceuticals

    $1,000
    Marketing Fee maximum: $1,000 per month per territory
    2026 FDD · Item 6 · PDF p. 15

    System scale & health

    Total outlets (Item 20)

    Discovery Map International

    116
    Outlets at end of 2025
    2026 FDD · Item 20 · PDF p. 34

    Galt Pharmaceuticals

    63
    Outlets at end of 2025
    2026 FDD · Item 20 · PDF p. 48
    Net outlet change (Item 20)

    Discovery Map International

    +1
    Calculated: 115 at end of 2023 → 116 at end of 2025

    Galt Pharmaceuticals

    −3
    Calculated: 66 at end of 2023 → 63 at end of 2025
    Outlet exits (Item 20)

    Discovery Map International

    Not available
    No complete exit records for a year

    Galt Pharmaceuticals

    0
    Closures, terminations & non-renewals in 2025 · Calculated turnover 0.0% of outlets at start of year
    2026 FDD · Item 20 · PDF p. 48
    Franchising since (Item 1)

    Discovery Map International

    Not available
    Not in reviewed records

    Galt Pharmaceuticals

    Not available
    Not in reviewed records
    Franchisor founded (Item 1)

    Discovery Map International

    Not available
    Not in reviewed records

    Galt Pharmaceuticals

    Not available
    Not in reviewed records

    Financial performance (Item 19), by location group

    Discovery Map International
    Locations counted not stated in the reviewed record — Franchised maps published in fiscal 2025 completing full sales cycle
    $53,210
    other sales per map
    2026 FDD · Item 19 · PDF p. 33
    Locations counted not stated in the reviewed record — Maps included in FPR
    37 percent
    other Proportion of maps achieving or surpassing average sales
    2026 FDD · Item 19 · PDF p. 33
    Locations counted not stated in the reviewed record — Franchised maps that completed a full sales cycle and were published in fiscal…
    $58,171
    other sales per map
    2026 FDD · Item 19 · PDF p. 33
    Galt Pharmaceuticals
    Locations counted not stated in the reviewed record — Bottom third of 24 Operational Franchise Outlets; reporting period 2025.
    $12,142
    other Bottom third
    2026 FDD · Item 19 · PDF p. 46
    Locations counted not stated in the reviewed record — Middle third of 24 Operational Franchise Outlets; reporting period 2025.
    $66,763
    other Middle third
    2026 FDD · Item 19 · PDF p. 46
    Locations counted not stated in the reviewed record — Top third of 24 Operational Franchise Outlets; reporting period 2025.
    $813,752
    other Top third
    2026 FDD · Item 19 · PDF p. 46
    +1 more groups in the full report

    Item 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.

    Discovery Map International vs Galt Pharmaceuticals: common questions

    Which costs less to open, Discovery Map International or Galt Pharmaceuticals?
    Discovery Map International: $29,250 (2026 FDD · Item 7 · PDF p. 13); Galt Pharmaceuticals: $122,350 – $348,700 (2026 FDD · Item 7 · PDF p. 21). These are each franchisor's Item 7 estimated initial investment. The low end of the disclosed estimate is lower for Discovery Map International. Estimates are not quotes, and the FDD years may differ.
    Which has more locations, Discovery Map International or Galt Pharmaceuticals?
    Discovery Map International: 116 (2026 FDD · Item 20 · PDF p. 34); Galt Pharmaceuticals: 63 (2026 FDD · Item 20 · PDF p. 48). Total outlets from Item 20. Outlet counts do not indicate territory availability or franchisee results.
    Do Discovery Map International and Galt Pharmaceuticals disclose financial performance (Item 19)?
    Discovery Map International has reviewed Item 19 figures for 3 location groups; Galt Pharmaceuticals has reviewed Item 19 figures for 4 location groups. Different location groups are not directly comparable, and revenue is not profit.

    Answers restate the reviewed figures above. Not a ranking or recommendation.

    How Franopolis reviews FDD figures

    Keep researching